http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108451979-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-01 |
| filingDate | 2018-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108451979-B |
| titleOfInvention | Lycopene compound preparation with auxiliary treatment effect on prostate cancer and application thereof |
| abstract | The invention relates to the technical field of medicines, and provides a lycopene compound preparation with an auxiliary treatment effect on prostate cancer and application thereof. The preparation comprises the following components in parts by weight: 1-20 parts of lycopene, 1-20 parts of phytosterol or phytosterol ester, 0.1-10 parts of selenium-containing compound and 0.1-10 parts of zinc-containing compound. It has tumor cell inhibiting effect; can inhibit the growth of prostate fibroblast, inhibit the proliferation of tumor and vascular endothelial cell, regulate prostate immune cell, and has proliferation effect on T cell subgroup of immune cell in prostate. |
| priorityDate | 2018-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.